DOI QR코드

DOI QR Code

The efficacy and safety of transcatheter closure of atrial septal defect with Amplatzer septal occluder in young children less than 3 years of age

3세 미만 심방중격결손 소아에서 Amplatzer 기구 폐쇄술의 안전성 및 효용성

  • Lee, Soo Hyun (Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Choi, Deok Young (Division of Pediatric Cardiology, Gil Heart Center, Gachon University of Medicine) ;
  • Kim, Nam Kyun (Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Choi, Jae Young (Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Sul, Jun Hee (Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine)
  • 이수현 (연세대학교 의과대학 심장혈관병원, 소아심장과) ;
  • 최덕영 (가천의과대학교병원 의과대학 소아과학교실) ;
  • 김남균 (연세대학교 의과대학 심장혈관병원, 소아심장과) ;
  • 최재영 (연세대학교 의과대학 심장혈관병원, 소아심장과) ;
  • 설준희 (연세대학교 의과대학 심장혈관병원, 소아심장과)
  • Received : 2008.09.16
  • Accepted : 2008.11.06
  • Published : 2009.04.15

Abstract

Purpose : Applicability of transcatheter closure of atrial septal defect (ASD) has been expanded by accumulation of clinical experiences and evolutions of the device. This study was performed to evaluate the safety and efficacy of transcatheter closure of ASD with Amplatzer septal occluder (ASO) in young children less than 3 years of age. Methods : From May 2003 to December 2005, 295 patients underwent transcatheter closure of ASD with ASO in the Severance Cardiovascular Hospital, Yonsei University Health System. Among them, 51 patients less than 3 years of age were enrolled in this study. We investigated procedural success rate, rate of residual shunt, frequency of complications, procedure/fluoroscopy time, and need of modified techniques for device implantation. Results : The median age was 2.1 years and median body weight was 12 kg. Implantation of device was successful in 50 patients (98%). Seven patients (15%) showed a small residual shunt 1 day after the procedure, but complete occlusion had been documented at 6 month follow-up in all patients (100%). The pulmonary to systemic flow ratio (Qp/Qs), peak systolic pulmonary artery pressure, and peak systolic right ventricular pressure had decreased significantly after closure of ASD. There were 2 complications including device embolization (1, 2%) and temporary groin hematoma (1, 2%). Conclusion : Transcatheter closure of ASD with ASO can be performed with satisfactory results and acceptable risk even in young children less than 3 years of age. We could suggest that even in very young children with ASD, there is no need to wait until they grow to a sufficient size for the transcatheter closure.

목 적 : 심방중격결손의 기구 폐쇄술은 현재 소아 영역에서 수술을 대체할 치료법으로 광범위하게 사용되고 있으나 수술과 비교하였을 때 적절한 시행 시기는 명확하지 않다. 본 연구에서는 3세 미만의 심방중격결손 소아에서 기구 폐쇄술의 안전성, 효용성 및 임상 결과를 평가하여 시술을 시행하기에 적절한 시기를 알아보고자 하였다. 방 법 : 2003년 5월부터 2005년 12월까지 연세대학교 의과대학 심장혈관병원 소아심장과에서 Amplatzer septal occluder(ASO)를 이용한 심방중격결손의 기구 폐쇄술을 시행 받은 환자 295명 중 3세 미만 소아 51명을 대상으로 하였다. 시술 소요 시간, 투시 검사 시간, 폐쇄 성공률, 잔류 단락율, 합병증의 종류 및 발생 빈도를 조사하였고, 기구 장착 전후의 체폐순환비, 폐동맥압, 우심실압을 측정하였으며 시술 후 1일, 1개월, 6개월, 12개월 및 이후 1년 간격으로 경흉부 심초음파를 시행하여 추적 관찰하였다. 결 과 : 대상 환자의 75% (38/51)가 여자였으며, 시술 당시 연령은 $2.0{\pm}0.6$세, 체중은 $11.8{\pm}1.7$ kg, 심방 중격 결손의 크기는 $16.6{\pm}3.6$ mm, 이들의 체폐순환비는 $2.4{\pm}0.9$이었고, 기구 폐쇄술 시행 후 추적 관찰 기간은 $19.8{\pm}6.4$개월이었다. 시술의 폐쇄성공률은 98% (50/51), 소요 시간은 $87.7{\pm}23.6$분, 방사선 투시 시간은 $31.8{\pm}14.7$분이었으며 잔류 단락은 시술 후 24시간 뒤 51명중 7명(15%)에서 관찰되었으나, 최종 추적 관찰 시에는 모두 폐쇄되었다. 폐쇄술 시행 전과 시행 직후의 체폐순환비는 $2.4{\pm}0.9$에서 $1.4{\pm}0.3$ (P<0.001)으로, 주폐동맥압은 $28.4{\pm}6.4$ mmHg에서 $25.5{\pm}5.6$ mmHg (P=0.04)로, 우심실압은 $41.3{\pm}11.8$ mmHg에서 $32.6{\pm}7.9$ mmHg (P<0.001)로 감소하였다. 대상 환자 중 2명에서 시술과 관련한 합병증이 있었으며 기구 이탈과 관련한 우심방 색전증 1예, 서혜부에 발생한 혈종 1예가 관찰되었다. 결 론 : 심방중격결손 소아에서 ASO를 이용한 경피적 심방중격결손 폐쇄술은 3세 미만의 작은 소아에서 안전하고 효과적으로 시행할 수 있으며 더 성장하기까지 시술을 연기할 필요는 없는 것으로 생각된다. 작은 영아에서의 효용성과 안전성에 대해서는 더 광범위한 연구가 필요하다.

Keywords

References

  1. Benson LN, Freedom RM. Atrial septal defect. In: Freedom RM, Benson LN, Smalhorn JF, editors. Neonatal Heart Disease. London: Springer-Verlag, 1992:633-44
  2. Hoffman JE, Christianson R. Congenital heart disease in a cohort of 19,502 births with long term follow up. Am J Cardiol 1978;42:641-47 https://doi.org/10.1016/0002-9149(78)90635-5
  3. King TD, Mills NL. Secundum atrial septal defects: nonoperative closure during cardiac catheterization. JAMA 1974; 235:2506-9 https://doi.org/10.1001/jama.235.23.2506
  4. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 2003; 89:199-204 https://doi.org/10.1136/heart.89.2.199
  5. Lock JE, Rome JJ, Davis R, Van Praagh S, Perry SB, Van Praagh R, et al. Transcatheter closure of atrial septal defects: experimental studies. Circulation 1989;79:1091-9
  6. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997;42:388-93 https://doi.org/10.1002/(SICI)1097-0304(199712)42:4<388::AID-CCD7>3.0.CO;2-7
  7. Hijazi ZM, Cao Q, Patel HT, Rhodes J, Hanlon KM. Transesophageal echocardiographic results of catheter closure of atrial septal defect in children and adults using the Amplatzer device. Am J Cardiol 2000;85:1387-90 https://doi.org/10.1016/S0002-9149(00)00779-7
  8. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, Van Domburg R, Van Rijen EH, Utens EM, et al. Excellent survival and low incidence of arrhythmias, stoke and heart failure long term after surgical ASD closure at young age (a prospective follow up study of 21-33 years). Eur Heart J 2003;24:190-7
  9. Veldtman GR, Razack V, Siu S, El-Haii H, Walker F, Webb GD, et al. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol 2001;37:2108-13 https://doi.org/10.1016/S0735-1097(01)01305-5
  10. Kort HW, Balzer DT, Johnson MC. Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol 2001; 38:1528-32 https://doi.org/10.1016/S0735-1097(01)01547-9
  11. Choi JY. Recent advances in transcatheter treatment of congenital heart disease. Korean J Pediatr 2006;49:917-29 https://doi.org/10.3345/kjp.2006.49.9.917
  12. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, et al. Long term outcome after surgical repair of isolated atrial septal defect: follow up at 27 to 32 years. N Engl J Med 1990;323:1645-50 https://doi.org/10.1056/NEJM199012133232401
  13. Berger F, Ewert P, Bjornstad PG, Dahnert I, Krings G, Brilla-Austenat I, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young 1999;9:468-73
  14. Kalmar P, Irrgang E. Cardiac surgery in the Federal Republic of Germany during 1990: a report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 1991;39:167-9 https://doi.org/10.1055/s-2007-1013956
  15. Galal MO, Wobst A, Halees Z. Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients: a baseline study. Eur Heart J 1994;15:1381-4
  16. Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell septal umbrella. Am J Cardiol 1996;78:1310-2 https://doi.org/10.1016/S0002-9149(96)00620-0
  17. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-9 https://doi.org/10.1001/jama.235.23.2506
  18. Butera G, De Rosa G, Chessa M, Rosti L, Negura DG, Luciane P, et al. Transcatheter closure of atrial septal defect in young children: results and follow up. J Am Coll Cardiol 2003;42:241-45 https://doi.org/10.1016/S0735-1097(03)00589-8
  19. Thomson JD, Aburawi EH, Watterson KG, Van Doorn C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defect: a prospective comparison of results and cost. Heart 2002;87:466-69 https://doi.org/10.1136/heart.87.5.466
  20. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999;118:674-8 https://doi.org/10.1016/S0022-5223(99)70013-9
  21. McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, Tortoriello TA, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002;87:256-9 https://doi.org/10.1136/heart.87.3.256
  22. Andreas H, Ulrich P, Ulrike SM, Susanne GP, Christoph M. Predictors of spontaneous closure of isolated secundum atrial septal defect in children:A longitudinal study. Pediatrics 2006;118:1560-5 https://doi.org/10.1542/peds.2005-3037
  23. Mayer JE. Atrial septal defect. In: Castaneda AR, Jonas RA, Mayer JE, Hanley FL, editors. Cardiac Surgery of the Neonate and Infants. Philadelphia:WB Saunders Co, 1994: 143-50
  24. Cardenas L, Panzer J, Boshoff D, Malekzadeh-Milani S, Ovaert C. Transcatheter closure of secundum atrial defect in small children. Cathet Cardiovasc Intervent 2007;69:447- 52 https://doi.org/10.1002/ccd.21030
  25. Hijazi ZM, Celiker A. Closure of atrial septal defects. Anadolu Kardiyol Derg 2005;5:331
  26. Holzer R, Hijazi ZM. Interventional approach to congenital heart disease. Curr Opin Cardiol 2004;19:84-90 https://doi.org/10.1097/00001573-200403000-00003
  27. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006;151:228-34 https://doi.org/10.1016/j.ahj.2005.02.051
  28. Bialkowski J, Karwot B, Szkutnik M, Sredniawa B, Chodor B, Zeifert B, et al. Comparison of heart rate variability between surgical and interventional closure of atrial septal defect in children. Am J Cardiol 2003;92:356-8 https://doi.org/10.1016/S0002-9149(03)00648-9
  29. Kim NY, Kwon HJ, Choi DY, Jung MJ, Choi CH, Kim SH. Closure of secundum atrial septal defect: comparison between percutaneous and surgical occlusion. Korean J Pediatr 2007;50: 469-75 https://doi.org/10.3345/kjp.2007.50.5.469
  30. Apitz C, Ambrock C, Roller R, Kaulitz R, Sieverding L, Schmelz M, et al. Bacterial endocarditis of a recanalized Waterston-Cooley anastomosis: Interventional transcatheter occlusion with an Amplatzer-ASD occluder. Clin Res Cardiol 2007;96:51-5 https://doi.org/10.1007/s00392-006-0456-x
  31. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:302-9 https://doi.org/10.1016/j.jacc.2003.10.030
  32. Jea SJ, Kwon HJ, Jang GY, Lee JY, Kim SJ, Son CS, et al. Complications of transcatheter closure of atrial septal defects using the amplatzer septal occluder. Korean J Pediatr 2008; 51:401-8 https://doi.org/10.3345/kjp.2008.51.4.401
  33. Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999;82:300-6
  34. Rome JJ. Pediatric interventional catheterization: reasonable exceptations and outcomes. Pediatr Clin North Am 2004;51: 1589-610 https://doi.org/10.1016/j.pcl.2004.08.007
  35. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005;45:1213-8 https://doi.org/10.1016/j.jacc.2004.12.072
  36. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004;63:496-502 https://doi.org/10.1002/ccd.20211
  37. Meijboom F, Hess J, Szatmari A, Utents EM, McGhie J, Deckers JW, et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol 1993;72:1431-4 https://doi.org/10.1016/0002-9149(93)90192-F